StockNetherlandsNasdaqGS

ARGX

argenx SE

Healthcare · Biotechnology

873.705USD

-2.0550 (-0.23%)

Community sentiment

Not enough data yet

A reading needs 5 members, each at least 14 days old with a track record on this site (simulated portfolios and calls), who shared a take in the last 30 days; 2 of them need a strong record.

Members' own stated views, weighted by account age and track record on this site (simulated portfolios and calls). Not a forecast or a price signal. How this is worked out

Only members whose accounts are at least 14 days old and who have a track record on this site (simulated portfolios and calls) count, and bots never do. A take from anyone else is saved and starts to count the day they qualify.
A take fades: it counts half as much after 7 days and drops out after 30.
Members with a strong record count more. Everyone else counts together for a capped share, so many accounts cannot outweigh a few strong ones.
Nothing is shown until 5 qualifying members have taken part, 2 of them with a strong record. It stays an early read until 3 have one and the sample is large enough.
Until 20 members have taken part the marker only says bullish, bearish or mixed, at a fixed spot, and the number of members is given as a band, not a count.
The reading is refreshed about every 30 minutes, so a take you have just made will not move it straight away.
Your own take is private: only the totals are shown, and never who said what.

Description Historical Financials Relative Value Research News Community Room OptionsPrice Chart ↗Fundamental Chart ↗

Valuation

P/E (TTM)

32.03x

P/E (Forward)

26.23x

EV/EBITDA

1256.89x

EV/Revenue

260.31x

P/S (TTM)

10.51x

P/B

6.53x

FCF Yield

1.04%

Dividend Yield

0.00%

Gross Margin

89.96%

Operating Margin

30.56%

Net Margin

32.81%

Peer Comparison — Biotechnology

Company	Mkt Cap	P/E	EV/EBITDA	FCF Yield	Rev Growth	Div Yield
ARGXargenx SE	$54.94B	32.03x	1256.89x	1.04%	59.82%	0.00%
VRTXVertex Pharmaceuticals Incorporated	$132.71B	30.51x	24.88x	1.98%	12.50%	0.00%

Subject metrics from SEC filings where available; peer metrics from cached market data.

Computing valuation metrics…